Impact of one versus two doses of mesenchymal stromal cells on lung and cardiovascular repair in experimental emphysema

Stem Cell Research and Therapy

Volumn 9, Issue 1, 2018, Pages

  Poggio, Hananda A ^a   Antunes, Mariana A ^a   Rocha, Nazareth N ^a,b   Kitoko, Jamil Z ^a   Morales, Marcelo M ^a,c   Olsen, Priscilla C ^a   Lopes Pacheco, Miquéias ^a,c   Cruz, Fernanda F ^a,c   Rocco, Patricia R M ^a,c  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^c National Institute for Science and Technology Translational Medicine   (Brazil)

Author keywords

Animal models; Collagen fiber; Elastic fiber; Emphysema; Heart; Immunosuppression; Inflammation

Indexed keywords

KERATINOCYTE DERIVED CHEMOKINE; PANCREATIC ELASTASE; SODIUM CHLORIDE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR; VASCULOTROPIN; AUTACOID; COLLAGEN; ELASTIN;

AIRWAY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL; BRONCHOALVEOLAR LAVAGE FLUID; CARDIOVASCULAR REPAIR; CD4 LYMPHOCYTE COUNT; CD8+ T LYMPHOCYTE; CELL COUNT; CELL DOSE; CELL TRANSPLANTATION; CERVICAL LYMPH NODE; COLLAGEN FIBER; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SEVERITY; ELASTASE-INDUCED EMPHYSEMA; ELASTIC FIBER; FEMALE; HEART FUNCTION; HISTOPATHOLOGY; IMMUNOSUPPRESSIVE TREATMENT; KERATINOCYTE; LUNG EMPHYSEMA; LUNG HOMOGENATE; LUNG MECHANICS; LUNG PARENCHYMA; LUNG REPAIR; LYMPHOCYTE COUNT; MACROPHAGE; MESENCHYMAL STROMA CELL; MOUSE; MURINE MODEL; NEUTROPHIL COUNT; NONHUMAN; ORGAN WEIGHT; PRIORITY JOURNAL; PROTEIN ANALYSIS; PULMONARY HYPERTENSION; THERAPY EFFECT; THYMUS WEIGHT; TISSUE REPAIR; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CARDIOVASCULAR SYSTEM; CYTOLOGY; INFLAMMATION; LUNG; LYMPHOID TISSUE; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; WOUND HEALING;

ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CARDIOVASCULAR SYSTEM; COLLAGEN; ELASTIN; FEMALE; IMMUNOSUPPRESSION; INFLAMMATION; INFLAMMATION MEDIATORS; LUNG; LYMPHOID TISSUE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MICE, INBRED C57BL; PULMONARY EMPHYSEMA; WOUND HEALING;

EID: 85056270061     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/s13287-018-1043-6     Document Type: Article

References (54)

1. From the Global Initiative for Chronic Obstructive Lung Disease (GOLD). 2018 Global Strategy for Prevention, Diagnosis and Management of COPD. http://goldcopd.org/wp-content/uploads/2017/11/GOLD-2018-v6.0-FINAL-revised-20-Nov-WMS.pdf. Accessed 6 May 2018.
2. Donner CF, Johann CV, Lusuardi M. Pharmacoeconomics in COPD and inappropriateness of diagnostics, management and treatment. Respir Med. 2011;105:828-37.
3. Rabe KF, Watz H. Chronic obstructive pulmonary disease. Lancet. 2017;389:1931-40.
4. Tomita H, Yamashiro T, Matsuoka S, Matsushita S, Nakajima Y. Correlation between heart size and emphysema in patients with chronic obstructive pulmonary disease: CT-based analysis using inspiratory and expiratory scans. Chron Respir Dis. 2017. https://doi.org/10.1177/1479972317741896.
5. Antunes MA, Lapa E, Silva JR, Rocco PR. Mesenchymal stromal cell therapy in COPD: from the bench to bedside. Int J Chron Obstruct Pulmon Dis. 2017;12:3017-27.
6. Cho RJ, Kim YS, Kim JY, Ym O. Human adipose-derived mesenchymal stem cell spheroids improve recovery in a mouse model of elastase-induced emphysema. BMB Rep. 2017;50:79-84.
7. Peron JP, de Brito AA, Pelatti M, Brandão WN, Vitoretti LB, Freiffo FR, et al. Human tubal-derived mesenchymal stromal cells associated with low level laser therapy significantly reduces cigarette smoke-induced COPD in C57BL/6 mice. PLoS One. 2015;10:e0136942.
8. Ingenito EP, Tsai L, Murthy S, Tyagi S, Mazan M, Hoffman A. Autologous lung-derived mesenchymal stem cell transplantation in experimental emphysema. Cell Transplant. 2012;21:175-89.
9. Schweitzer KS, Johnstone BH, Garrison J, Rush NI, Cooper S, Traktuev DO, et al. Adipose stem cell treatment in mice attenuates lung and systemic injury induced by cigarette smoking. Am J Respir Crit Care Med. 2011;183:215-25.
10. Antunes MA, Abreu SC, Cruz FF, Teixeira AV, Lopes-Pacheco M, Bandeira E, et al. Effects of different mesenchymal stromal cell sources and delivery routes in experimental emphysema. Respir Res. 2014;15:118.
11. Rocha NN, de Oliveira MV, Braga CL, Guimarães G, Maia LA, Padilha GA, et al. Ghrelin therapy improves lung and cardiovascular function in experimental emphysema. Respir Res. 2017;18:185.
12. Abreu SC, Lopes-Pacheco M, da Silva AL, Xisto DG, de Oliveira TB, Kitoko JZ, et al. Eicosapentaenoic acid enhances the effects of mesenchymal stromal cell therapy in experimental allergic asthma. Front Immunol. 2018;9:1147.
13. Cruz FF, Borg ZD, Goodwin M, Coffey AL, Wagner DE, Rocco PR, et al. CD11b+ and Sca-1+ cells exert the main beneficial effects of systemically administered bone marrow-derived mononuclear cells in a murine model of mixed Th2/Th17 allergic airway inflammation. Stem Cells Transl Med. 2016;5:488-99.
14. Henriques I, Lopes-Pacheco M, Padilha GA, Marques OS, Magalhães RF, Antunes MA, et al. Moderate aerobic training improves cardiorespiratory parameters in elastase-induced emphysema. Front Physiol. 2016;7:329.
15. Lang RL, Bierig M, Devereux RB, Glachskampf FA, Foster E, Pellikka PA, et al. Chamber Quantification Writing Group, American Society of Echocardiography-s Guidelines and Standards Committee, European Association of Echocardiography. J Am Soc Echocardiogr. 2005;18:1440-63.
16. Oliveira MV, Abreu SC, Padilha GA, Rocha NN, Maia LA, Takiya CM, et al. Characterization of a mouse model of emphysema induced by multiple instillations of low-dose elastase. Front Physiol. 2016;7:457.
17. Bates JH, Ludwig MS, Sly PD, Brown K, Marin JG, Fredberg JJ. Interrupter resistance elucidated by alveolar pressure measurement in open-chest normal dogs. J Appl Physiol. 1988;65:408-14.
18. Padilha GA, Henriques I, Lopes-Pacheco M, Abreu SC, Oliveira MV, Morales MM, et al. Therapeutic effects of LASSBio-596 in an elastase-induced mouse model of emphysema. Front Physiol. 2015;6:267.
19. Hsia CC, Hyde DM, Ochs M, Weibel ER. An official research policy statement of the American Thoracic Society/European Respiratory Society: standards for quantitative assessment of lung structure. Am J Respir Crit Care Med. 2010;181:394-418.
20. Cruz FF, Antunes MA, Abreu SC, Fujisaki LC, Silva JD, Xisto DG, et al. Protective effects of bone marrow mononuclear cell therapy on lung and heart in an elastase-induced emphysema model. Respir Physiol Neurobiol. 2012;182:26-36.
21. Olsen PC, Kitoko JZ, Ferreira TP, de-Azevedo CT, Arantes AC, Martins MA. Glucocorticoids decrease Treg cell numbers in lungs of allergic mice. Eur J Pharmacol. 2015;747:52-8.
22. Kitoko JZ, Nascimento AP, Abreu SC, Cruz FF, Arantes AC, Xisto DG, et al. Therapeutic administration of bone-marrow derived mesenchymal stromal cells reduced airway inflammation without upregulating Tregs in experimental asthma. Clin Exp Allergy. 2018;48:205-16.
23. Majo J, Ghezzo H, Cosio MG. Lymphocyte population and apoptosis in the lungs of smokers and their relation to emphysema. Eur Respir J. 2001;17:946-53.
24. Sullivan AK, Simonian PL, Falta MT, Mitchell JD, Cosgrove GP, Brown KK, et al. Oligoclonal CD4+ T cells in lungs of patients with severe emphysema. Am J Respir Crit Care Med. 2005;172:590-6.
25. Sales DS, Ito JT, Zanchetta IA, Annino R, Aun MV, Ferraz LFS, et al. Regulatory T-cell distribution within lung compartments in COPD. COPD. 2017;14:533-42.
26. Ghorani V, Boskabady MH, Khazdair MR, Kianmeher M. Experimental animal models for COPD: a methodological review. Tob Induc Dis. 2017;15:25.
27. Suki B, Bartolák-Suki E, Rocco PRM. Elastase-induced lung emphysema models in mice. Methods Mol Biol. 2017;1639:67-75.
28. Lüthje L, Raupach T, Michels H, Unsöld B, Hasenfuss G, Kögler H, et al. Exercise intolerance and systemic manifestations of pulmonary emphysema in a mouse model. Respir Res. 2009;10:7.
29. Tibboel J, Keijzer R, Reiss I, de Jongste JC, Post M. Intravenous and intratracheal mesenchymal stromal cell injection in a mouse model of pulmonary emphysema. COPD. 2014;11:310-8.
30. Kusuma GD, Carthew J, Lim R, Frith JE. Effect of the microenvironment on mesenchymal stem cell paracrine signaling: opportunity to engineer the therapeutic effect. Stem Cells Dev. 2017;26:617-31.
31. Silva JD, Lopes-Pacheco M, Paz AHR, Cruz FF, Melo EB, de Oliveira MV, et al. Mesenchymal stem cells from bone marrow, adipose tissue, and lung tissue differentially mitigate lung and distal organ damage in experimental acute respiratory distress syndrome. Crit Care Med. 2018;46:e132-40.
32. Fu Y, Karbaat L, Wu L, Leijten J, Both SK, Larperien M. Trophic effects of mesenchymal stem cells in tissue regeneration. Tissue Eng Part B Rev. 2017;23:515-28.
33. Gu W, Song L, Li XM, Wang D, Guo XJ, Xu WG. Mesenchymal stem cells alleviate airway inflammation and emphysema in COPD through down-regulation of cyclooxygenase-2 via p38 and ERK MAPK pathways. Sci Rep. 2015;5:8733.
34. Kennelly H, Mahon BP, Englosh K. Human mesenchymal stromal cells exert HGP dependent cytoprotective effects in a human relevant pre-clinical model of COPD. Sci Rep. 2016;6:38207.
35. Barnes PJ. The cytokine network in asthma and chronic obstructive pulmonary disease. J Clin Invest. 2008;118:3546-56.
36. Kurtagic E, Jadrychowski MP, Nugent MA. Neutrophil elastase cleaves VEGF to generate a VEGF fragment with altered activity. Am J Phys Lung Cell Mol Phys. 2009;296:L534-46.
37. Keatings VM, Collins PD, Scott DM, Barnes PJ. Differences in interkeukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med. 1996;153:530-4.
38. Sambamurthy N, Leme AS, Oury TD, Shapiro SD. The receptor for advanced glycation end products (RAGE) contributes to the progression of emphysema in mice. PLoS One. 2015;10:e0118979.
39. Gadgil A, Duncan SR. Role of T-lymphocytes and pro-inflammatory mediators in the pathogenesis of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2008;3:531-41.
40. Masopust D, Schenkel JM. The integration of T cell migration, differentiation and function. Nat Rev Immunol. 2013;13:309-20.
41. Vuillemenot BR, Rodrigues JF, Hoyle GW. Lymphoid tissue and emphysema in the lungs of transgenic mice inducibly expressing tumor necrosis factor-alpha. Am J Respir Cell Mol Biol. 2004;30:438-48.
42. Glennie S, Soeiro I, Dyson PJ, Lam EW, Dazzi F. Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells. Blood. 2005;105:2821-7.
43. Benvenuto F, Ferrari S, Gerdoni E, Gualandi F, Frassoni F, Pistoia V, et al. Human mesenchymal stem cells promote survival of T cells in a quiescent state. Stem Cells. 2007;25:1753-60.
44. Haddad R, Saldanha-Araujo F. Mechanisms of T-cell immunosuppression by mesenchymal stromal cells: what do we know so far? Biomed Res Int. 2014;2014:216806.
45. Rasmusson I, Ringdén O, Sundberg B, Le Blanc K. Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells. Transplantation. 2003;76:1208-13.
46. Takizawa H, Tanaka M, Takami K, Ohtoshi T, Ito K, Satoh M, et al. Increased expression of transforming growth factor-beta1 in small airway epithelium from tobacco smokers and patients with chronic obstructive pulmonary disease (COPD). Am J Respir Crit Care Med. 2001;163:1476-83.
47. Lopes-Pacheco M, Xisto DG, Ornellas FM, Antunes MA, Abreu SC, Rocco PR, et al. Repeated administration of bone marrow-derived cells prevents disease progression in experimental silicosis. Cell Physiol Biochem. 2013;32:1681-94.
48. Thébaud B, Ladha F, Mechelakis ED, Sawicka M, Thurston G, Eaton F, et al. Vascular endothelial growth factor gene therapy increases survival, promotes lung angiogenesis, and prevents alveolar damage in hyperoxia-induced lung injury: evidence that angiogenesis participates in alveolarization. Circulation. 2005;112:2477-86.
49. Aguero J, Ishikawa K, Hadri L, Santos-Gallego C, Fish K, Hammoudi N, et al. Characterization of right ventricular remodeling and failure in a chronic pulmonary hypertension model. Am J Physiol Heart Circ Physiol. 2014;307:H1204-15.
50. Guan XJ, Song L, Hann FF, Cui ZL, Chen X, Guo XJ, et al. Mesenchymal stem cells protect cigarette smoke-damaged lung and pulmonary function partly via VEGF-VEGF receptors. J Cell Biochem. 2013;114:323-35.
51. Shigemura N, Okumura M, Mizuno S, Imanishi Y, Nakamura T, Sawa Y. Autologous transplantation of adipose tissue-derived stromal cells ameliorates pulmonary emphysema. Am J Transplant. 2006;6:2592-600.
52. Bates JH, Davis GS, Majumdar A, Butnor KJ, Suki B. Linking parenchymal disease progression to changes in lung mechanical function by percolation. Am J Respir Crit Care Med. 2007;176:617-23.
53. Hamakawa H, Bartolak-Suki E, Parameswaran H, Majumdar A, Lutchen KR, Suki B. Structure-function relations in an elastase-induced mouse model of emphysema. Am J Respir Cell Mol Biol. 2011;45:517-24.
54. Winkler T, Suki B. Emergent structure-function relations in emphysema and asthma. Crit Rev Biomed Eng. 2011;39:263-80.